HUT75244A - Pharmaceutical composition containing azithromycin - Google Patents

Pharmaceutical composition containing azithromycin Download PDF

Info

Publication number
HUT75244A
HUT75244A HU9501206A HU9501206A HUT75244A HU T75244 A HUT75244 A HU T75244A HU 9501206 A HU9501206 A HU 9501206A HU 9501206 A HU9501206 A HU 9501206A HU T75244 A HUT75244 A HU T75244A
Authority
HU
Hungary
Prior art keywords
azithromycin
dosage form
food
tablet
suspension
Prior art date
Application number
HU9501206A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9501206D0 (en
Inventor
William J Curatolo
George H Foulds
Hylar L Friedman
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22883977&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUT75244(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of HU9501206D0 publication Critical patent/HU9501206D0/hu
Publication of HUT75244A publication Critical patent/HUT75244A/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
HU9501206A 1994-04-29 1995-04-27 Pharmaceutical composition containing azithromycin HUT75244A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/235,069 US5605889A (en) 1994-04-29 1994-04-29 Method of administering azithromycin

Publications (2)

Publication Number Publication Date
HU9501206D0 HU9501206D0 (en) 1995-06-28
HUT75244A true HUT75244A (en) 1997-05-28

Family

ID=22883977

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9501206A HUT75244A (en) 1994-04-29 1995-04-27 Pharmaceutical composition containing azithromycin

Country Status (31)

Country Link
US (2) US5605889A (zh)
EP (1) EP0679400B1 (zh)
JP (3) JPH07300420A (zh)
KR (1) KR100354310B1 (zh)
CN (1) CN1088362C (zh)
AP (1) AP566A (zh)
AT (1) ATE183395T1 (zh)
AU (1) AU709328B2 (zh)
CA (1) CA2148071C (zh)
CO (1) CO4560547A1 (zh)
DE (1) DE69511451T2 (zh)
DK (1) DK0679400T3 (zh)
DZ (1) DZ1877A1 (zh)
ES (1) ES2136247T3 (zh)
FI (1) FI952060A (zh)
GR (1) GR3031290T3 (zh)
HU (1) HUT75244A (zh)
IL (1) IL113437A (zh)
LV (1) LV10918B (zh)
MA (1) MA23533A1 (zh)
NO (1) NO314386B1 (zh)
NZ (1) NZ548384A (zh)
OA (1) OA10151A (zh)
RU (1) RU2128998C1 (zh)
SI (1) SI0679400T1 (zh)
TN (1) TNSN95046A1 (zh)
TW (1) TW499311B (zh)
UA (1) UA34464C2 (zh)
UY (1) UY23935A1 (zh)
YU (1) YU49483B (zh)
ZA (1) ZA953439B (zh)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO114740B1 (ro) † 1994-05-06 1999-07-30 Pfizer Compozitie cu eliberare controlata, procedeu de obtinere a acesteia si metoda de tratament
ES2079327B1 (es) * 1994-12-13 1996-08-01 Lilly Sa Formulaciones farmaceuticas de cefaclor.
ATE216576T1 (de) * 1995-02-08 2002-05-15 Yamanouchi Europ Bv Vehrfahren zur herstellung von beta-lactam antibiotikum enthaltenden oralen dosisformen
US20060003447A1 (en) * 2003-12-30 2006-01-05 Richard Fike Dry powder cells and cell culture reagents and methods of production thereof
US6383810B2 (en) * 1997-02-14 2002-05-07 Invitrogen Corporation Dry powder cells and cell culture reagents and methods of production thereof
US20030212123A1 (en) * 1997-05-05 2003-11-13 Pfizer Inc. COX-2 selective carprofen for treating pain and inflammation in dogs
US6146655A (en) * 1997-08-29 2000-11-14 Softy-Flex Inc. Flexible intra-oral bandage and drug delivery system
US6129932A (en) * 1997-09-05 2000-10-10 Merck & Co., Inc. Compositions for inhibiting platelet aggregation
US6861411B1 (en) * 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
US5955107A (en) * 1997-12-12 1999-09-21 Fmc Corporation Pharmaceutical suspension tablet compositions
US5916594A (en) * 1997-12-22 1999-06-29 Schering Corporation Process of making solid ribavirin dosage forms
CA2300452C (en) * 1997-12-22 2000-11-28 Schering Corporation Orally administrable solid ribavirin dosage forms and process for making them
US5914128A (en) * 1997-12-22 1999-06-22 Schering Corporation Orally administrable solid dosage form
US6239112B1 (en) * 1998-07-09 2001-05-29 Merial, Inc. Water miscible macrolide solutions
FR2793690B1 (fr) * 1999-03-30 2003-01-03 Cll Pharma Formulations pharmaceutiques en macrolides seuls ou associes a d'autres principes actifs et leur utilisation en therapeutique
US6239113B1 (en) 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US7056893B2 (en) * 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
EP1611881A1 (en) * 1999-03-31 2006-01-04 Janssen Pharmaceutica N.V. Pregelatinized starch in a controlled release formulation
IL141438A0 (en) * 2000-02-23 2002-03-10 Pfizer Prod Inc Method of increasing the bioavailability and tissue penetration of azithromycin
ATE320441T1 (de) * 2000-07-25 2006-04-15 Silanes Sa De Cv Lab Einstufiges verfahren zur herstellung von 7,16-
DE60114028T2 (de) 2000-08-23 2006-07-13 Wockhardt Ltd. Verfahren zur herstellung von wasserfreiem azithromycin
AU3240602A (en) * 2000-11-06 2002-05-15 Invitrogen Corp Dry powder cells and cell culture reagents and methods of production thereof
EP1344527B1 (en) * 2000-11-15 2009-09-09 Masao Sugamata Macrolide antibiotics for endometriosis or uterine myoma
HRP20010301A2 (en) * 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
EP1671979B1 (en) 2001-05-22 2008-08-13 Pfizer Products Inc. New Cristal Form of Azithromycin
NZ529118A (en) * 2001-05-22 2005-10-28 Pfizer Prod Inc Crystal forms of azithromycin
EA200400214A1 (ru) * 2001-08-21 2004-06-24 Пфайзер Продактс Инк. Азитромицин в виде разовой дозы
GB0123400D0 (en) 2001-09-28 2001-11-21 Novartis Ag Organic compounds
AU2006218279B2 (en) * 2001-09-28 2009-12-10 Novartis Ag Pharmaceutical compositions comprising colloidal silicon dioxide
EP1541134A3 (en) * 2001-10-18 2007-06-06 Teva Pharmaceutical Industries Limited Stabilized azithromycin compositions
US20080149521A9 (en) * 2001-10-18 2008-06-26 Michael Pesachovich Methods of stabilizing azithromycin
US20040226852A1 (en) * 2003-02-19 2004-11-18 Michael Pesachovich Method of stabilizing azithromycin
DE60232005D1 (de) * 2001-10-18 2009-05-28 Teva Pharma Stabilisierte azithromycin-zusammensetzungen
NZ532707A (en) * 2001-12-21 2006-07-28 Pfizer Prod Inc Directly compressible formulations of azithromycin
IL161259A0 (en) * 2001-12-21 2004-09-27 Pfizer Prod Inc Methods for wet granulating azithromycin
EP1476191A2 (en) * 2002-01-16 2004-11-17 Pepgen Corporation Oral administration of interferon-tau
NZ534234A (en) * 2002-02-01 2007-05-31 Pfizer Prod Inc Dry granulated formulations of non-dihydrate form of azithromycin
EP1490031A1 (en) * 2002-03-07 2004-12-29 Vectura Limited Fast melt multiparticulate formulations for oral delivery
US7101576B2 (en) * 2002-04-12 2006-09-05 Elan Pharma International Limited Nanoparticulate megestrol formulations
US20100226989A1 (en) * 2002-04-12 2010-09-09 Elan Pharma International, Limited Nanoparticulate megestrol formulations
US9101540B2 (en) 2002-04-12 2015-08-11 Alkermes Pharma Ireland Limited Nanoparticulate megestrol formulations
US20040105889A1 (en) * 2002-12-03 2004-06-03 Elan Pharma International Limited Low viscosity liquid dosage forms
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
BG748Y1 (bg) * 2002-07-02 2005-06-30 "BALKANFARMA-RAZGRAD" AD A{ô­{òM{}ö{ }{GC}{D A{DAAAAAAAAAAAAAAAAAAAAAAAAAA ЛЕКАРСТВЕНАБФОРМАБББББББББББББББББББББББББББББББББФЕДЙГБФЕХгЦдв@ЖЦЩФ@@@@@@@@@@@
CA2524827A1 (en) * 2003-05-06 2004-11-25 Nirmal Mulye Controlled release formulation of erythromycin derivatives
US20050013835A1 (en) * 2003-07-15 2005-01-20 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
EP1648473B1 (en) * 2003-07-24 2009-01-28 PLIVA HRVATSKA d.o.o. Single dose fast dissolving azithromycin
TWI366442B (en) 2003-07-30 2012-06-21 Novartis Ag Palatable ductile chewable veterinary composition
US20050089502A1 (en) * 2003-08-21 2005-04-28 Todd Schansberg Effervescent delivery system
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
CA2547597A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
EP1689368B1 (en) * 2003-12-04 2016-09-28 Bend Research, Inc Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions
MXPA06005913A (es) * 2003-12-04 2006-06-27 Pfizer Prod Inc Formas de dosificacion de multiparticulas de azitromicina por procedimientos basados en liquidos.
CN1889931A (zh) * 2003-12-04 2007-01-03 辉瑞产品公司 利用挤压器制备优选含泊洛沙姆和甘油酯的多重粒子阿奇霉素组合物的喷雾－冻凝方法
CN1889932A (zh) * 2003-12-04 2007-01-03 辉瑞产品公司 制备药用多颗粒的方法
AU2004216676B2 (en) * 2003-12-04 2011-06-16 Pfizer Products Inc. Azithromycin dosage forms with reduced side effects
US20050131079A1 (en) * 2003-12-10 2005-06-16 Pujara Chetan P. Cefdinir oral suspension
WO2005067500A2 (en) * 2003-12-30 2005-07-28 3M Innovative Properties Company Enhancement of immune responses
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
JP4713104B2 (ja) * 2004-08-04 2011-06-29 ファイザー株式会社 アジスロマイシン類を有効成分とする苦味が抑制された安定な組成物
US20060046970A1 (en) * 2004-08-31 2006-03-02 Insite Vision Incorporated Topical otic compositions and methods of topical treatment of prevention of otic infections
US20060182806A1 (en) * 2004-11-08 2006-08-17 Mintong Guo Extended-release propranolol composition
DE05815688T1 (de) * 2005-01-27 2008-06-26 Alembic Ltd. Levetiracetam-formulierung mit verlängerter freisetzung
US20060198895A1 (en) * 2005-03-07 2006-09-07 Kotliar Eleonora M Azithromycin powder for oral suspension compositions
AU2005328689A1 (en) * 2005-03-07 2006-09-14 Teva Pharmaceutical Industries Ltd. Azithromycin powder for oral suspension compositions
EP2422783B1 (en) 2005-05-26 2015-04-08 Sumitomo Dainippon Pharma Co., Ltd. Pharmaceutical Composition
KR101465803B1 (ko) * 2005-08-10 2014-11-26 시오노기세이야쿠가부시키가이샤 구강내 붕괴 정제
US20070191271A1 (en) * 2006-02-10 2007-08-16 Dow Pharmaceutical Sciences Method for stabilizing polypeptides lacking methionine
US8187659B2 (en) 2006-05-02 2012-05-29 Jerry Robertson Real Estate Llc Solid medicament dosage form consumption aid
US20080014264A1 (en) * 2006-07-13 2008-01-17 Ucb, S.A. Novel pharmaceutical compositions comprising levetiracetam
US8124123B2 (en) * 2007-09-05 2012-02-28 Dow Pharmaceutical Sciences, Inc. Controlled release azithromycin solid dosages forms
TWI478712B (zh) 2008-09-30 2015-04-01 Astellas Pharma Inc 釋控性醫藥組成物
WO2011122524A1 (ja) 2010-03-29 2011-10-06 アステラス製薬株式会社 放出制御医薬組成物
WO2013088274A1 (en) 2011-12-14 2013-06-20 Wockhardt Limited Anhydrous amorphous azithromycin composition free of azithromycin dihydrate
DE112013000869T5 (de) 2012-02-06 2014-10-16 Merial Ltd. Orale parasitizide Veterinärzusammensetzungen umfassend systemisch wirkende Wirkstoffe, Verfahren und Verwendun davon
CN104168895B (zh) 2012-02-28 2020-02-21 首尔制药株式会社 包含西地那非作为活性成分的掩蔽苦味的高含量快速溶解膜
RU2498805C1 (ru) * 2012-07-23 2013-11-20 Открытое акционерное общество "Биосинтез" Твердая лекарственная форма азитромицина
CN104177457A (zh) * 2013-05-23 2014-12-03 长春海悦药业有限公司 一种阿奇霉素药物原料及其制剂和用途
CA2939604A1 (en) * 2013-11-11 2015-05-14 Forest Laboratories Holdings Limited Compositions and methods of treatment comprising fosfomycin disodium
RU2649834C1 (ru) * 2016-07-06 2018-04-04 Фармалидер С.А. Фармацевтическая композиция силденафила цитрата в форме суспензии для перорального применения

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4382085A (en) * 1982-03-01 1983-05-03 Pfizer Inc. 4"-Epi erythromycin A and derivatives thereof as useful antibacterial agents
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
UA27040C2 (uk) 1987-07-09 2000-02-28 Пфайзер Інк. Кристалічhий дигідрат азитроміциhу та спосіб одержаhhя кристалічhого дигідрату азитроміциhу
WO1989002271A1 (en) * 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents
SI9011409A (en) * 1990-07-18 1995-10-31 Pliva Pharm & Chem Works O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
KR930702369A (ko) * 1990-10-15 1993-09-08 우에노 아키라 에리쓰로마이신 또는 그의 유도체의 2'위치 수식 화합물
TW271400B (zh) 1992-07-30 1996-03-01 Pfizer
AU7957994A (en) 1993-10-01 1995-05-01 Procter & Gamble Company, The Use of azithromycin for the treatment of adult periodontitis and topical compositions for this use
RO114740B1 (ro) 1994-05-06 1999-07-30 Pfizer Compozitie cu eliberare controlata, procedeu de obtinere a acesteia si metoda de tratament

Also Published As

Publication number Publication date
CA2148071C (en) 2000-10-17
YU49483B (sh) 2006-08-17
RU95106639A (ru) 1997-01-20
IL113437A (en) 2001-04-30
FI952060A (fi) 1995-10-30
ZA953439B (en) 1996-10-28
NZ548384A (en) 2008-04-30
JP2005015466A (ja) 2005-01-20
GR3031290T3 (en) 1999-12-31
DE69511451T2 (de) 1999-12-09
CN1088362C (zh) 2002-07-31
UY23935A1 (es) 1995-09-12
US5605889A (en) 1997-02-25
EP0679400A1 (en) 1995-11-02
UA34464C2 (uk) 2001-03-15
TW499311B (en) 2002-08-21
LV10918B (en) 1996-06-20
OA10151A (en) 1996-12-18
CO4560547A1 (es) 1998-02-10
JPH07300420A (ja) 1995-11-14
AP9500728A0 (en) 1995-04-30
DE69511451D1 (de) 1999-09-23
ES2136247T3 (es) 1999-11-16
RU2128998C1 (ru) 1999-04-20
DK0679400T3 (da) 1999-12-06
YU27195A (sh) 1999-03-04
IL113437A0 (en) 1995-07-31
CN1114879A (zh) 1996-01-17
AU709328B2 (en) 1999-08-26
LV10918A (lv) 1995-12-20
AU1771195A (en) 1995-11-09
FI952060A0 (fi) 1995-04-28
EP0679400B1 (en) 1999-08-18
TNSN95046A1 (fr) 1996-02-06
NO314386B1 (no) 2003-03-17
HU9501206D0 (en) 1995-06-28
ATE183395T1 (de) 1999-09-15
CA2148071A1 (en) 1995-10-30
NO951630L (no) 1995-10-30
NO951630D0 (no) 1995-04-28
KR100354310B1 (ko) 2002-12-26
MA23533A1 (fr) 1995-12-31
USRE39149E1 (en) 2006-06-27
DZ1877A1 (fr) 2002-02-17
KR950028764A (ko) 1995-11-22
JP2008231120A (ja) 2008-10-02
SI0679400T1 (en) 1999-10-31
AP566A (en) 1996-11-22

Similar Documents

Publication Publication Date Title
HUT75244A (en) Pharmaceutical composition containing azithromycin
RU2335280C2 (ru) Таблетки тамзулосина с модифицированным высвобождением
FI90393B (fi) Menetelmä oraalisen, farmaseuttisen valmisteen valmistamiseksi, joka on pysyvä värin muuttumista vastaan
KR100493836B1 (ko) 옥스카르바제핀을 포함하는 제약 조성물
EA000804B1 (ru) Твердая лекарственная форма, содержащая производные цизаприда, способ ее получения, продукт, содержащий твердую лекарственную форму, фармацевтическая упаковка
IE51506B1 (en) Suspension of microencapsulated bacampicillin acid addition salt for oral,especially pediatric,administration
KR960011772B1 (ko) 개선된 디데옥시 퓨린 뉴클레오사이드 경구 투여 제제
BRPI0414860B1 (pt) uso de composição de fenofibrato em um medicamento para tratar hipertrigliceridemias, hipercolesterolemias ou hiperlipidemias ao mesmo tempo que reduzindo o efeito da alimentação sobre a biodisponibilidade de fenofibrato
US20150050336A1 (en) Taste Masking System For Non-Plasticizing Drugs
US20070053975A1 (en) Ramipril formulation
KR20190019061A (ko) 지연된 방출 경구 탐술로신 하이드로클로라이드
HU229569B1 (hu) Szelektív szerotoninújrafelvétel-gátlók szabályozott kibocsátású többrészecskés kiszerelései
JP2511577B2 (ja) アルギン酸プロピレングリコ―ルエステルからなる徐放性製剤
MXPA04006165A (es) Suspension farmaceutica para administracion oral.
AU744318B2 (en) Method of administering azithromycin
JP4842960B2 (ja) 低水溶性薬物とともに使用することによく適した圧縮固体状投与形態の製造方法およびそれにより製造された圧縮固体状投与形態
KR20000050265A (ko) 아지스로마이신 경구 투여 제형을 포함하는 치료용 패키지

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees